Impact of Safety-Related Regulatory Action on Clinical Practice: A Systematic Review by Piening, Sigrid, Haaijer-Ruskamp, Flora M., de Vries, Jonie T. N., van der Elst, Menno E., de Graeff, Pieter A., Straus, Sabine M. J. M., Mol, Peter G. M.

Get full text

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies by Bloem, Lourens T., Vreman, Rick A., Peeters, Niels W. L., Hoekman, Jarno, Elst, Menno E., Leufkens, Hubert G. M., Klungel, Olaf H., Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K.

Get full text

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs by Vreman, Rick A, Bloem, Lourens T, van Oirschot, Stijn, Hoekman, Jarno, van der Elst, Menno E, Leufkens, Hubert Gm, Klungel, Olaf H, Goettsch, Wim G, Mantel-Teeuwisse, Aukje K

Get full text

A Pharmaceutical Care Program to Improve Adherence to Statin Therapy: A Randomized Controlled Trial by Eussen, Simone RBM, Elst, Menno E van der, Klungel, Olaf H, Rompelberg, Cathy JM, Garssen, Johan, Oosterveld, Marco H, Boer, Anthonius de, Gier, Johan J de, Bouvy, Marcel L

Get full text

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs by Bloem, Lourens T., Bot, Rosa E., Mantel‐Teeuwisse, Aukje K., Elst, Menno E., Sonke, Gabe S., Klungel, Olaf H., Leufkens, Hubert G. M., Hoekman, Jarno

Get full text

Influence of the use of functional foods enriched with phytosterols/-stanols on adherence to statin therapy by Eussen, Simone R. B. M., Bouvy, Marcel L., Rompelberg, Cathy J. M., van der Elst, Menno E., Garssen, Johan, Oosterveld, Marco H., de Boer, Anthonius, de Gier, Johan J., van Kranen, Henk J., Klungel, Olaf H.

Get full text

Effect of drug combinations on admission for recurrent myocardial infarction by van der Elst, Menno E, Bouvy, Marcel L, de Blaey, Cornelis J, de Boer, Anthonius

Get full text

Impact of Safety-Related Regulatory Action on Clinical Practice by Piening, Sigrid, Haaijer-Ruskamp, Flora M, de Vries, Jonie TN, van der Elst, Menno E, de Graeff, Pieter A, Straus, Sabine MJM, Mol, Peter GM

Get full text

Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: A retrospective analysis by van der Elst, Menno E., Bouvy, Marcel L., de Blaey, Cornelis J., de Boer, Anthonius

Get full text

Improving Pharmacotherapy After Myocardial Infarction by Group Academic Detailing Using Feedback Data on a Patient Level by van der Elst, Menno E., Bouvy, Marcel L., de Blaey, Cornelis J., de Boer, Anthonius

Get full text

Drug Therapy for Prevention of Recurrent Myocardial Infarction by van der Elst, Menno E, Buurma, Henk, Bouvy, Marcel L, de Boer, Anthonius

Get full text

Oral Antithrombotic Use Among Myocardial Infarction Patients by van der Elst, Menno E, Cisneros-Gonzalez, Nelly, de Blaey, Cornelis J, Buurma, Henk, de Boer, Anthonius

Get full text

The simple observational critical care studies: estimations by students, nurses, and physicians of in-hospital and 6-month mortality by Cox, Eline G M, Onrust, Marisa, Vos, Madelon E, Paans, Wolter, Dieperink, Willem, Koeze, Jacqueline, van der Horst, Iwan C C, Wiersema, Renske

Get full text